
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1602798
[patent_doc_number] => 06432977
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Salts of quinoline derivatives as NK3 antagonists'
[patent_app_type] => B1
[patent_app_number] => 09/994076
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6424
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432977.pdf
[firstpage_image] =>[orig_patent_app_number] => 09994076
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/994076 | Salts of quinoline derivatives as NK3 antagonists | Nov 5, 2001 | Issued |
Array
(
[id] => 7611176
[patent_doc_number] => 06841680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-11
[patent_title] => 'N-type calcium channel antagonists for the treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 10/415783
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8987
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415783 | N-type calcium channel antagonists for the treatment of pain | Oct 30, 2001 | Issued |
Array
(
[id] => 7468547
[patent_doc_number] => 20040053964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'N-type calcium channel antagonists for the treatment of pain'
[patent_app_type] => new
[patent_app_number] => 10/415774
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10875
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053964.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415774
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415774 | N-type calcium channel antagonists for the treatment of pain | Oct 30, 2001 | Issued |
Array
(
[id] => 5815427
[patent_doc_number] => 20020040143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Method of making metal 8-quinolinolato complexes'
[patent_app_type] => new
[patent_app_number] => 09/996871
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4632
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20020040143.pdf
[firstpage_image] =>[orig_patent_app_number] => 09996871
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/996871 | Method of making metal 8-quinolinolato complexes | Oct 30, 2001 | Abandoned |
Array
(
[id] => 6783563
[patent_doc_number] => 20030065011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Substituted pyridines as selective cyclooxygenase-2 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/021187
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21814
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20030065011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021187 | Substituted pyridines as selective cyclooxygenase-2 inhibitors | Oct 29, 2001 | Issued |
Array
(
[id] => 5829464
[patent_doc_number] => 20020068829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Process of preparing 3S-3-amino-3-aryl proprionic acid and derivatives thereof'
[patent_app_type] => new
[patent_app_number] => 10/021369
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6955
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021369
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021369 | Process of preparing 3S-3-amino-3-aryl proprionic acid and derivatives thereof | Oct 28, 2001 | Issued |
Array
(
[id] => 6131528
[patent_doc_number] => 20020077336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => '(7-(3-Carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine'
[patent_app_type] => new
[patent_app_number] => 10/005587
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6035
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077336.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005587 | (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine | Oct 28, 2001 | Issued |
Array
(
[id] => 1570814
[patent_doc_number] => 06498254
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Antiretroviral compounds and compositions'
[patent_app_type] => B1
[patent_app_number] => 10/021202
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11449
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 370
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021202
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021202 | Antiretroviral compounds and compositions | Oct 28, 2001 | Issued |
Array
(
[id] => 6684211
[patent_doc_number] => 20030120075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Stereospecific enrichment of heterocyclic enantiomers'
[patent_app_type] => new
[patent_app_number] => 09/999613
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9307
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20030120075.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999613
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999613 | Stereospecific enrichment of heterocyclic enantiomers | Oct 24, 2001 | Issued |
Array
(
[id] => 1286127
[patent_doc_number] => 06638945
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-28
[patent_title] => 'Quinoline derivatives as inhibitors of MEK enzymes'
[patent_app_type] => B1
[patent_app_number] => 09/959434
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13623
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1572
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/638/06638945.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959434
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959434 | Quinoline derivatives as inhibitors of MEK enzymes | Oct 24, 2001 | Issued |
Array
(
[id] => 6409950
[patent_doc_number] => 20020038029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Method for the synthesis of quinoline derivatives'
[patent_app_type] => new
[patent_app_number] => 09/981185
[patent_app_country] => US
[patent_app_date] => 2001-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9578
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20020038029.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981185
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981185 | Method for the synthesis of quinoline derivatives | Oct 16, 2001 | Abandoned |
Array
(
[id] => 7616884
[patent_doc_number] => 06946557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-20
[patent_title] => 'Process for producing optically active ethyl (3R, 5S, 6E)-7-[2-cycloproply-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate'
[patent_app_type] => utility
[patent_app_number] => 10/398915
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4769
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398915 | Process for producing optically active ethyl (3R, 5S, 6E)-7-[2-cycloproply-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate | Oct 11, 2001 | Issued |
Array
(
[id] => 6278805
[patent_doc_number] => 20020107264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Cyclic sulfone containing retroviral protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/973991
[patent_app_country] => US
[patent_app_date] => 2001-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15347
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107264.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973991
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973991 | Cyclic sulfone containing retroviral protease inhibitors | Oct 10, 2001 | Issued |
Array
(
[id] => 6538032
[patent_doc_number] => 20020193407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Modulators of CCR5 chemokine receptor activity'
[patent_app_type] => new
[patent_app_number] => 09/973920
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31274
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193407.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973920 | Modulators of CCR5 chemokine receptor activity | Oct 9, 2001 | Issued |
Array
(
[id] => 935523
[patent_doc_number] => 06974873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-13
[patent_title] => 'Modified carbocyanine dyes and their conjugates'
[patent_app_type] => utility
[patent_app_number] => 09/969853
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26370
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/974/06974873.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969853
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969853 | Modified carbocyanine dyes and their conjugates | Sep 30, 2001 | Issued |
Array
(
[id] => 6132090
[patent_doc_number] => 20020077487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Modified carbocyanine dyes and their conjugates'
[patent_app_type] => new
[patent_app_number] => 09/968401
[patent_app_country] => US
[patent_app_date] => 2001-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25178
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077487.pdf
[firstpage_image] =>[orig_patent_app_number] => 09968401
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/968401 | Modified carbocyanine dyes and their conjugates | Sep 28, 2001 | Issued |
Array
(
[id] => 1414160
[patent_doc_number] => 06528655
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Aromatic derivatives with HIV integrase inhibitory properties'
[patent_app_type] => B1
[patent_app_number] => 09/963329
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36651
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528655.pdf
[firstpage_image] =>[orig_patent_app_number] => 09963329
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/963329 | Aromatic derivatives with HIV integrase inhibitory properties | Sep 25, 2001 | Issued |
Array
(
[id] => 5875123
[patent_doc_number] => 20020049328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate, as well as salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and composition comprising the same as active ingredient'
[patent_app_type] => new
[patent_app_number] => 09/961364
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24924
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049328.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961364
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961364 | PROCESSES FOR PRODUCING 7-ISOINDOLINE-QUINOLONECARBOXYLIC ACID DERIVATIVE AND ITS INTERMEDIATE, AS WELL AS SALT OF 7-ISOINDOLINE-QUINOLONECARBOXYLIC ACID DERIVATIVE, ITS HYDRATE AND COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT | Sep 24, 2001 | Issued |
Array
(
[id] => 7605299
[patent_doc_number] => 07115630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Metabotropic glutamate receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/381987
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23674
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381987
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381987 | Metabotropic glutamate receptor antagonists | Sep 24, 2001 | Issued |
Array
(
[id] => 6664578
[patent_doc_number] => 20030203904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/381363
[patent_app_country] => US
[patent_app_date] => 2003-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17389
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381363 | Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors | Sep 17, 2001 | Issued |